Saltar a contenido principal
Saltar a Buscador
Saltar a menú servicios
Saltar a Noticias y Convocatorias - Menú principal. Secciones - - Fin de Menú principal -
- Título de la Sección Seleccionada - - Título de la Sección Seleccionada -
plataformas
- Información de interés -
foto1
foto2
- Fin de Información de interés -
- Información principal -

Home >> S&T Platforms >> National Genotyping Centre

The Spanish National Genotyping Centre (CeGen)

 

The Spanish National Genotyping Centre (Centro Nacional de Genotipado - CeGen ) is a service platform created by Genoma España to carry out large scale genotyping projects. The aim is to identify thousands of mutations per genome, in a high number of preferably human samples. This type of research was previously not possible in our country due to the lack of necessary infrastructure.

The CeGen will respond to the needs of the Spanish research groups through Spanish population genotyping services aimed at establishing the molecular bases of the most prevalent diseases of our environment and at understanding the genetic basis for the variation between individuals' responses to medicines.

It will also conduct its own research in these areas and will work together with other international platforms and consortiums of this field. It will ensure that its services are kept up to date by constantly incorporating state-of-the-art technologies.

In summary, the CeGen will result in clear social advantages, including à-la-carte therapy or customised medicine, estimating risk and predicting drug responses.

It will also offer genotyping services in relation to plants and other animals of economic relevance to our country whose genomes have been partially or fully sequenced.

 

Investment

€15.1 million in 5 years (2004-2008). 

 

Structure

The Spanish National Genotyping Centre has a nodal structure:

Coordination Unit:
Director, Dr Jaime Bertranpetit, Pompeu Fabra University.

  • Node 1. SNPlex (a medium to large scale genotyping technology capable of analysing 4 million genotypes per year), Taqman (a small to medium scale genotyping technology capable of analysing 625,000 genotypes per year).
    Barcelona: Genomic Regulation Centre and Pompeu Fabra University (Director: Dr Xavier Estivill). 
     
  • Node 2. Illumina (a large scale genotyping technique capable of analysing 25 million genotypes per year) and Taqman.
    Madrid: Spanish National Oncology Research Centre (CNIO) (Director: Dr Javier Benítez). 
     
  • Node 3. Sequenom (a medium to large scale genotyping technology capable of analysing 1.5 million genotypes per year) and SNPlex.
    Santiago de Compostela: Santiago de Compostela University (Director: Dr Ángel Carracedo). 

Current status

With its various techniques, the CeGen 's genotyping analysis capability is similar to that of any other country of our environment. Spain has gone from analysing a few genotypes per year to a capacity of 800,000 a week, which can double with only a few additional resources if the country so demands.

It has already had requests, and is providing services since June 2005.

- Buscador -
- Menu de Servicios -
Services
- Últimas Noticias o Eventos -
Highlights
Notice
Pedro Teixeira, 8, planta 2 - 28020 Madrid
Request for Applications
Open Valorization Period
Request for Applications
Open Registration Period
Link
Supercomputing Centre of Castilla and Leon
Report
Challenges in Implementing more Preventive Medicine and Focused on Early Treatment
Request for Applications
Open Registration Period
Report
Comprehensive analysis of the relevance of biotechnology in Spain and its progress during the period 2000-2008
Offers
Summary and results of the 2009 Client Satisfaction Survey

© Genoma España. Actualizado Enero 2010. Aviso legal | Mapa Web
C/ Pedro Teixeira, 8 – 2ª planta. 28020 Madrid, España. Tel.: +3491 449 12 50. Fax.: +34 91 571 54 89.  info@gen-es.org

 


 

XHTML 1.0 Strict Valido   Nivel Doble-A de Conformidad   CSS válida